These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7009418)

  • 21. Two new Bf S subtypes revealed by isoelectric focusing and immunofixation.
    Weidinger S; Schwarzfischer F; Burgemeister R; Cleve H
    Hum Genet; 1984; 68(1):90-2. PubMed ID: 6568200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Properdin factor B(Bf) polymorphism in the population of Veneto, Italy.
    Crestani C; Caenazzo L; Cortivo P; Scorretti C; Caenazzo C
    Z Rechtsmed; 1988; 101(2):81-5. PubMed ID: 3188673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properdin factor B and acute lymphocytic leukemia (ALL).
    Budowle B; Acton RT; Barger BO; Blackstock R; Crist W; Go RC; Humphrey GB; Ragab A; Roper M; Vietti T; Dearth J
    Cancer; 1982 Dec; 50(11):2369-71. PubMed ID: 6958349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HLAB*18,BF*F1 in haplotype in type 1 diabetes.
    Walsh LJ; Cox DW; Ehrlich RM
    Am J Med Genet; 1982 Mar; 11(3):337-43. PubMed ID: 6952765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping of C2, Bf, and C4 genes to the swine major histocompatibility complex (swine leukocyte antigen).
    Lie WR; Rothschild MF; Warner CM
    J Immunol; 1987 Nov; 139(10):3388-95. PubMed ID: 2890688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA A*, B*-BF* and C4 A*, B* allele associations, with special reference to BF*S07, in the Tunisian population.
    Helal AN; Lefranc G; Hauptmann G; Goetz J; Tongio MM; Davrinche C; Rivat C; Cavelier B; Chibani J; Chaabani H
    J Immunogenet; 1983 Jun; 10(3):205-8. PubMed ID: 6576063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of properdin factor B with melanoma.
    Budowle B; Barger BO; Balch CM; Go RC; Roseman JM; Acton RT
    Cancer Genet Cytogenet; 1982 Mar; 5(3):247-51. PubMed ID: 6917774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Bf F1 and Haplotype HLA-B18, Bf F1 with insulin-dependent diabetes mellitus.
    Bertrams J; Baur MP; Grüneklee D; Hintzen U
    Immunobiology; 1980; 158(1-2):129-33. PubMed ID: 7009410
    [No Abstract]   [Full Text] [Related]  

  • 29. Age relationship between insulin-dependent diabetes and rare alleles of properdin factor B.
    Kirk RL; Serjeantson SW; Theophilus J; Zimmet P; Whitehouse S; Court JM
    Lancet; 1979 Sep; 2(8141):537. PubMed ID: 90267
    [No Abstract]   [Full Text] [Related]  

  • 30. HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM).
    Cambon-de Mouzon A; Ohayon E; Hauptmann G; Sevin A; Abbal M; Sommer E; Vergnes H; Ducos J
    Tissue Antigens; 1982 May; 19(5):366-79. PubMed ID: 6955994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Another association between the properdin system (BF) and insulin-dependent diabetes in south India.
    Kirk RL; Ranford PR; Viswanathan M; Mohan V; Ramachandran A; Snehalatha C; Munirathnam Chetty SM; John L
    Tissue Antigens; 1983 Aug; 22(2):170-1. PubMed ID: 6555961
    [No Abstract]   [Full Text] [Related]  

  • 32. Bf polymorphism and its relationship with HLA antigens in a sample of the Spanish Population: high BfF1 frequencies.
    Rodriguez-Córdoba S; Bootello A; Arnaiz-Villena A
    Tissue Antigens; 1981 Feb; 17(2):231-7. PubMed ID: 6908966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA and genetics of IDDM. Holism vs. reductionism?
    Segall M
    Diabetes; 1988 Aug; 37(8):1005-8. PubMed ID: 3292321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Another family with a silent allele of properdin factor B polymorphism (BF QO).
    Bertrams J; Mauff G
    Hum Genet; 1985; 70(4):321-3. PubMed ID: 3848405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properdin factor B polymorphism in Black Americans.
    Budowle B; Go RC; Barger BO; Acton RT
    J Immunogenet; 1981 Dec; 8(6):519-21. PubMed ID: 6916776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properdin factor B-polymorphism. An indication for the existence of a Bf O-allele.
    Weidinger S; Schwarzfischer F; Cleve H
    Z Rechtsmed; 1979 Aug; 83(3):259-64. PubMed ID: 291240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphism of properdin factor B in Japanese. Description of a rare variant and data of association with HLA and C2.
    Tokunaga K; Araki C; Juji T; Omoto K
    Hum Genet; 1982; 60(1):42-5. PubMed ID: 6918356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allelic variants for complement factors C3, C4, and B in acute necrotizing ulcerative gingivitis.
    Melnick SL; Go RC; Cogen RB; Roseman JM
    J Dent Res; 1988 May; 67(5):851-4. PubMed ID: 3163352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bf group system in the Polish population.
    Mańczak M
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):431-41. PubMed ID: 6570692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes.
    Rich S; O'Neill G; Dalmasso AP; Nerl C; Barbosa J
    Diabetes; 1985 May; 34(5):504-9. PubMed ID: 3987976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.